Liminatus Pharma, Inc. (LIMN) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-18 | 8-K | Listing Notice, Item 3.03, Charter Amendments, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-08-04 | 8-K | Shareholder Vote Results | SEC |
| 2026-07-30 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-24 | 8-K | Listing Notice, Other Events, Financial Statements & Exhibits | SEC |
| 2026-07-06 | 8-K | Material Agreement, Acquisition or Disposition, Unregistered Sales, Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-06-03 | 8-K | Material Agreement, Unregistered Sales, Item 3.03, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-27 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2026-05-20 | 8-K | Material Agreement, Financial Statements & Exhibits | SEC |
| 2026-03-04 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
| 2026-02-18 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2026-02-09 | 8-K | Material Agreement, Unregistered Sales, Financial Statements & Exhibits | SEC |
| 2026-01-26 | 8-K | Listing Notice | SEC |
| 2025-11-25 | 8-K | Listing Notice | SEC |
| 2025-08-25 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-08-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-07-17 | 8-K | Material Agreement, Unregistered Sales | SEC |
| 2025-07-11 | 8-K | Officer / Director Changes | SEC |
| 2025-07-03 | 8-K | Other Events | SEC |
| 2025-06-24 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-24 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-06-04 | 8-K | Listing Notice, Financial Statements & Exhibits | SEC |
| 2025-05-06 | 8-K | Material Agreement, Acquisition or Disposition, Unregistered Sales, Item 3.03, Auditor Change, Change in Control, Officer / Director Changes, Charter Amendments, Item 5.05, Item 5.06, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.